Ausgabe 12/2018
Inhalt (32 Artikel)
Prostate cancer imaging: when the game gets tough, the hard one gets done!
Laura Evangelista, Matteo Sepulcri, Marco Maruzzo
68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients
Paola Caroli, Israel Sandler, Federica Matteucci, Ugo De Giorgi, Licia Uccelli, Monica Celli, Flavia Foca, Domenico Barone, Antonino Romeo, Anna Sarnelli, Giovanni Paganelli
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer
Ali Afshar-Oromieh, Nils Debus, Monika Uhrig, Thomas A. Hope, Michael J. Evans, Tim Holland-Letz, Frederik L. Giesel, Klaus Kopka, Boris Hadaschik, Clemens Kratochwil, Uwe Haberkorn
Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
Kambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, Stefan Wagner, Michael Schäfers, Martin Bögemann, Matthias Weckesser
Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy
Michael Mix, Kathrin Reichel, Christian Stoykow, Mark Bartholomä, Vanessa Drendel, Eleni Gourni, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp T. Meyer, Cordula A. Jilg
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients
E. Incerti, S. Broggi, A. Fodor, M. Cuzzocrea, A. M. Samanes Gajate, P. Mapelli, C. Fiorino, I. Dell’Oca, M. Pasetti, M. Cattaneo, R. Calandrino, L. Gianolli, N. Di Muzio, Maria Picchio
Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging
Yonglin Pu, James X. Zhang, Haiyan Liu, Daniel Appelbaum, Jianfeng Meng, Bill C. Penney
Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Benedikt Michael Schaarschmidt, Johannes Grueneisen, Vanessa Stebner, Joachim Klode, Ingo Stoffels, Lale Umutlu, Dirk Schadendorf, Philipp Heusch, Gerald Antoch, Thorsten Dirk Pöppel
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience
Olarn Roengvoraphoj, Chukwuka Eze, Cherylina Wijaya, Maurice Dantes, Julian Taugner, Amanda Tufman, Rudolf Maria Huber, Peter Bartenstein, Claus Belka, Farkhad Manapov
Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription
Chi Lai Ho, Sirong Chen, Shing Kee Cheung, Yim Lung Leung, Kam Chau Cheng, Ka Nin Wong, Yuet Hung Wong, Thomas Wai Tong Leung
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis
Pierluigi Bonomo, A. Merlotti, E. Olmetto, A. Bianchi, I. Desideri, A. Bacigalupo, P. Franco, C. Franzese, E. Orlandi, L. Livi, S. Caini
Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters
Giacomo Maria Lima, Antonella Matti, Giulio Vara, Giulia Dondi, Nicoletta Naselli, Eugenia Maria De Crescenzo, Alessio Giuseppe Morganti, Anna Myriam Perrone, Pierandrea De Iaco, Cristina Nanni, Stefano Fanti
Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)
Onofrio A. Catalano, Lale Umutlu, Niccolo Fuin, Matthew Louis Hibert, Michele Scipioni, Stefano Pedemonte, Mark Vangel, Andreea Maria Catana, Ken Herrmann, Felix Nensa, David Groshar, Umar Mahmood, Bruce R. Rosen, Ciprian Catana
Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?
Luca Giovanella, Anca M. Avram, Jerome Clerc, Elif Hindié, David Taïeb, Frederik A. Verburg
[18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
Sazan Rasul, Sabrina Hartenbach, Katharina Rebhan, Adelina Göllner, Georgios Karanikas, Marius Mayerhoefer, Peter Mazal, Marcus Hacker, Markus Hartenbach
Quantification of myocardial blood flow with dynamic SPECT acquisitions: ready for prime time?
Fabien Hyafil, François Rouzet, Dominique Le Guludec
Feasibility of dynamic stress 201Tl/rest 99mTc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease
Sangwon Han, Young-Hak Kim, Jung-Min Ahn, Soo-Jin Kang, Jungsu S. Oh, Eonwoo Shin, Changhwan Sung, Sun Young Chae, Seung-Jung Park, Gillan Grimberg, Gil Kovalski, Dae Hyuk Moon
Sodium-fluoride PET-CT for the non-invasive evaluation of coronary plaques in symptomatic patients with coronary artery disease: a cross-correlation study with intravascular ultrasound
Li Li, Xiang Li, Yongping Jia, Jiamao Fan, Huifeng Wang, Chunyu Fan, Lei Wu, Xincheng Si, Xinzhong Hao, Ping Wu, Min Yan, Ruonan Wang, Guang Hu, Jianzhong Liu, Zhifang Wu, Marcus Hacker, Sijin Li
18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis
Mikaela L. McKenney-Drake, Mateen C. Moghbel, Koosha Paydary, Mouhamad Alloosh, Sina Houshmand, Sharon Moe, Ali Salavati, Jeffrey M. Sturek, Paul R. Territo, Connie Weaver, Thomas J. Werner, Poul Flemming Høilund-Carlsen, Michael Sturek, Abass Alavi
Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy
Sonja Stieb, Afroditi Eleftheriou, Geoffrey Warnock, Matthias Guckenberger, Oliver Riesterer
The SNMMI and EANM practice guideline for renal scintigraphy in adults
M. Donald Blaufox, Diego De Palma, Andrew Taylor, Zsolt Szabo, Alain Prigent, Martin Samal, Yi Li, Andrea Santos, Giorgio Testanera, Mark Tulchinsky
Radiochemotherapy-induced reactivation of scar tissue on 18F-FDG PET/CT
Axel Van Damme, Fréderic Duprez, Peter Tomassen, David Creytens, Ingeborg Goethals
Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
A. Michael Peters, Georgia Keramida, Deborah Pencharz
Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis
Nicolas Aide, Thibault Salomon, Charline Lasnon
Could we avoid computing TMTV of DLBCL patients in routine practice?
Eric Laffon, Roger Marthan
90Y-radioembolization of hepatocellular carcinoma from a theranostic perspective: towards a personalized approach
Luca Filippi, Orazio Schillaci, Oreste Bagni
Delivering PET imaging results to cancer patients: steps for handling ethical issues
Sandra Gonzalez, Eric Guedj, Stefano Fanti, Elisabetta Lalumera, Pierre Le Coz, David Taïeb
Martin Vahlensieck and Maximilian Reiser (Eds). MRI of the Musculoskeletal System, Second Edition
Antonio D’Addio, Luigi Mansi
Wael E. A. Saad: Portal hypertension. Imaging, diagnosis, and endovascular management. Third edition
Viola Vultaggio, Luigi Mansi
Correction to: Regulation of human brown adipose tissue by adenosine and A2A receptors – studies with [15O]H2O and [11C]TMSX PET/CT
Minna Lahesmaa, Vesa Oikonen, Semi Helin, Pauliina Luoto, Mueez U Din, Alexander Pfeifer, Pirjo Nuutila, Kirsi A. Virtanen
Correction to: PET imaging of EGFR expression using an 18F-labeled RNA aptamer
Siyuan Cheng, Orit Jacobson, Guizhi Zhu, Zhen Chen, Steve H. Liang, Rui Tian, Zhen Yang, Gang Niu, Xiaohua Zhu, Xiaoyuan Chen